
Mudar Patherya has put a little known small-cap on the center stage and confidently predicted that it will be “the next Ajanta Pharma”. The stock boasts of impeccable credentials and is well on the way to proving Mudar’s prediction correct
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Rakesh Jhunjhunwala
Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala
Recent Comments